Neurotensin is a
peptide with effects on appetite and intestinal
lipid absorption. Experimental data suggest a role in
glucose homeostasis, while human data is missing. Here, 20 morbidly obese subjects either underwent
biliopancreatic diversion with duodenal switch (BPD), or
Roux-en-Y gastric bypass (RYGB) in a randomized fashion. Before and 1 year after surgery, anthropometric data, body composition, clinical biochemistry,
insulin sensitivity by means of euglycemic hyperinsulinemic clamps (HEC) and fasting plasma
proneurotensin 1-117 were analyzed. Plasma
proneurotensin increased significantly more 1 year after BDP than RYGB (P = 0.028), while
weight loss was comparable. After
metabolic surgery,
proneurotensin correlated positively with
insulin sensitivity (M-value) (r = 0.55, P < 0.001), while an inverse relationship with fasting
glucose, HOMA-IR and HbA1c was observed (P < 0.05 for all components). After adjustment for age and gender,
proneurotensin and BMI remained independently related with delta of M-value (β = 0.46 and β = 0.51, P < 0.05, resp.). From these data we conclude that
proneurotensin positively correlates with
insulin sensitivity uniquely after
weight loss induced by
metabolic surgery in humans. BDP leads to a stronger increase in the
anorexigenic peptide compared to RYGB.